StockData
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc. (PYXS) stock

PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.41−0.03 (-2.08%)

Close on Nov 18, 2026Market cap $117.61MP/E –Yield –

Pyxis Oncology profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Pyxis Oncology's profit margin for the twelve months ending Dec 31, 2025 was -574.5%. For fiscal 2025 it was -574.5%, against -478.9% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-574.5%−95.6
FY2024Dec 31, 2024-478.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-164.0%–
Q2 FY2025Jun 30, 2025-650.9%–
Q1 FY2024Mar 31, 2024-20.2%–

More Pyxis Oncology figures

See a number that looks wrong?